Dermafence
Burn Treatment Technology
Startup Seed Health Tech & Life Sciences Est. 2017
Total Raised
$20K
Seed
Last Round
$10K
3 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
87/100
Patents
1
About
Dermafence has developed a proprietary technology for the treatment of burns. The company's technology is based on a GRAS formulation with a novel mechanism of action designed to bar energy from progressing to the deeper layers of the skin. Dermafence has developed a first aid burn formulation that restores and protects epidermal "skin barrier" function following exposure to insults that introduce energy to the skin.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2CB2B2C
Tags
burnsmedical-technologiespatientsmedical-productsdoctorsfirst-aid
Funding & Events
Mar 2018
Seed Undisclosed
MassChallenge (Lead)
Mar 2018
Non-equity $10K
Israel Innovation Authority
Jan 2017
Non-equity $10K
Israel Innovation Authority
Details
Product Stage
R&D
Employees
1-10
Exact Count
4
District
Jerusalem District
Founded
2017
Registrar
515654499
Crunchbase
dermafence
Locations
Professor Racah Street, Jerusalem, Israel
Links
Admin
Last Update
Sep 28, 2024
Verified by
Jenny Sotnik-Talisman
Missing
video or image, news, markets, external profiles, not claimed
Team (2)
Dr. Shulamit Richter Dayan
Founder & CEO
Founder
Joni Catalano-Sherman PhD
Business Development Manager
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2017-05-15T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)